Hyperbaric Oxygen Therapy for Compromised Grafts and Flaps

Under Pressure: 5 Surprising Ways Hyperbaric Oxygen Rescues Failing Reconstructive Surgeries

1. The hook: when perfection isn't enough

In the high-stakes theatre of reconstructive surgery, technical perfection is often the baseline, not the finish line. A surgeon can execute a flawless harvest and a meticulous microsurgical anastomosis, only to watch the tissue begin to succumb to a "nightmare scenario" in the recovery suite. The once-healthy pink of a skin flap may transform into the blue, turgid tint of venous congestion or the ashen, ghostly pallor of arterial ischaemia. When a graft or flap begins to fail due to factors beyond the reach of the scalpel - such as prior radiation, crushing trauma, or underlying hypoxia - the surgeon needs more than another suture. They need a specialised salvage technology.

Hyperbaric oxygen therapy (HBO₂) is not a general wellness tool or a routine requirement for uncompromised, healthy surgeries. It is a targeted, Class IB intervention designed specifically for compromised tissue. By delivering 100% oxygen at pressures typically between 2.0 and 2.5 atmospheres absolute (ATA), HBO₂ forces oxygen into solution in the plasma, providing a critical lifeline to tissues starved by ischaemia-reperfusion injury or metabolic demand.

2. The "vascular bridge": reimagining the recipient bed

The physiological survival of a reconstruction depends on how it interacts with its blood supply, and HBO₂ acts as a bridge for the two primary reconstructive methods:

• Avascular grafts: these tissues are harvested without a dedicated blood supply and are entirely dependent on the "recipient wound bed" for oxygenation and revascularisation. HBO₂ allows for larger grafts - such as the 2.0 cm composite grafts described in the Li et al. study - to thrive where they would normally exceed the bed's natural metabolic capacity.
• Inherent-supply flaps: these units include their own blood vessels but often face failure due to "random ischaemia" at the distal edges or microvascular collapse.

HBO₂ serves as the ultimate safety net, keeping cells viable "while revascularisation takes place." By stimulating angiogenesis (the growth of new vessels) and enhancing fibroblast function, the therapy sustains the tissue during the precarious window before a functional blood supply is established. This prevents the devastating cycle of graft loss and the consequent donor-site morbidity - the high physical cost of harvesting from a new, healthy part of the body to fix a failed primary site.

3. Neutralising the "nicotine tax" on healing

Nicotine is a surgeon's adversary, acting as a potent vasoconstrictor that restricts blood flow and impairs microvasculature. While many surgeons delay or refuse elective procedures for active smokers, HBO₂ offers a method to mitigate this "nicotine tax."

In pivotal animal models (Selcuk et al. and Demirtas et al.), nicotine exposure predictably decimated flap survival rates. However, the introduction of HBO₂ neutralised this handicap, bringing survival rates in nicotine-exposed subjects back to parity with healthy controls.

By restoring survival rates to near-normal levels, HBO₂ acts as a game-changer, allowing for the salvage of reconstructions in high-risk patients who would otherwise face near-certain necrosis.

4. The 24-hour "golden window"

In the world of surgical salvage, timing is the difference between a successful recovery and a total loss. "Expedient initiation" is the clinical mandate because the window for intervention is narrow. Once the microvasculature has completely collapsed, no amount of pressure can revive the tissue.

The Waterhouse et al. study provides a stark warning regarding the decline of success over time:

• Initiation within 24 hours: 89% complete salvage rate.
• Initiation between 1 to 3 days: only 25% salvage rate.
• Initiation after 3 days: 0% salvage rate.

This data emphasises that HBO₂ must be viewed as an urgent response, not a last resort. When signs of flap compromise appear, every hour that passes brings the tissue closer to irreversible microvascular collapse.

5. The power of 1+1=3: multimodal salvage strategies

The most sophisticated outcomes are rarely achieved through oxygen alone; instead, they rely on a multimodal salvage strategy. When HBO₂ is paired with other medical or biological agents, the synergistic effect can double the success rate of individual treatments.

• HBO₂ + pentoxifylline: pentoxifylline is a rheologic agent that improves "erythrocyte flexibility", allowing red blood cells to deform and flow through narrowed capillaries. When combined with HBO₂, research shows an 86% improvement over controls - a result nearly 40% more effective than using either therapy in isolation.
• HBO₂ + medicinal leeching: for cases of total venous occlusion (where blood enters the flap but cannot exit), HBO₂ alone is ineffective. However, when paired with medicinal leeches to mechanically drain the congestion, flap survival rates jump from 25% (leeching only) to 67%.

6. Saving the unsaveable: paediatric composite grafts

Perhaps the most impactful application of HBO₂ is in the salvage of traumatic injuries in children, such as dog bites or ear amputations. These often require "large composite grafts" (>1.5 x 1.5 cm) that include skin, fat, and cartilage. Because children face a lifetime of potential secondary surgeries and emotional distress if a facial feature is lost, the "morbidity benefit" of HBO₂ is immense.

A 2020 study by Camison et al. demonstrated that children with significant nasal or ear defects achieved a greater than 80% graft take when HBO₂ was initiated immediately post-op. By saving the original tissue, surgeons avoid the "second wound" of additional harvesting and the complexities of prosthetic reconstruction.

Conclusion: the future of oxygen-led salvage

Hyperbaric oxygen therapy is firmly established as a Class IB intervention for compromised grafts and flaps. Its ability to inhibit ischaemia-reperfusion injury, stimulate neovascularity, and bolster fibroblast function makes it a cornerstone of modern reconstructive technology.

As we look toward the future of surgical planning, a fundamental question emerges: given the high financial and physical costs of a failed flap, should HBO₂ be a "just in case" standby for every high-risk reconstruction? For the modern surgeon, the evidence suggests that the proactive application of oxygen under pressure is no longer just an adjunct - it is a vital tool for ensuring that technical perfection translates into clinical success.

This feature article is general educational information and does not replace advice from your own doctor. Whether hyperbaric oxygen is appropriate depends on individual circumstances. Portions were drafted with the assistance of AI tools and reviewed by Dr Gregory Weir; please verify clinical details against primary sources.